ArticleBioinformatics advances2025
KinMethyl: robust methylation detection in prokaryotic SMRT sequencing via kinetic signal modeling and deep feature integration.
Article in Bioinformatics advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Epigenetic regulation and antimicrobial resistance: functional roles of DNA methylation.FEMS microbiology reviews · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Motivation: Accurate detection of 5-methylcytosine (5mC) from PacBio single-molecule real-time (SMRT) sequencing remains challenging in prokaryotes due to weak kinetic signals and motif diversity. Results: Here, we present KinMethyl, a generalizable deep learning framework that integrates sequence and kinetic signals to improve methylation detection across diverse bacterial genomes. Central to our approach is a regression model trained on whole-genome amplified samples to estimate the expected kinetics signals of unmethylated sequences. These predicted signals are incorporated into a downstream classifier to enhance the performance under low signal-to-noise conditions. KinMethyl outperforms existing tools such as kineticstools and ccsmeth across multiple bacterial species, methylation motifs, and modification types not only 5mC but also N6-methyladenine (6 mA) and N4-methylcytosine (4mC). In 5mC classification, KinMethyl improved the AUC by up to 0.20 compared to the existing method (0.6165 to 0.8190) with statistical significance (DeLong's test, Availability and implementation: The source code is available at https://github.com/ZhangBio/KinMethyl.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.